Novartis AG is 126.0x more valuable than Ultragenyx Pharmaceutical Inc. by market capitalization ($283.13 B vs $2.25 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RARE | NVS |
|---|---|---|
| Market cap | $2.25 B | $283.13 B |
| US-listed rank | #2019 | #47 |
| Revenue (latest FY) | $673.00M | - |
| Net income (latest FY) | -$575.00M | - |
| Net margin | -85.4% | - |
| SEC filings | 1,100 | 947 |
Novartis AG is 126.0x more valuable than Ultragenyx Pharmaceutical Inc. by market capitalization ($283.13 B vs $2.25 B).
Full pages: Ultragenyx Pharmaceutical Inc. and Novartis AG, or browse the full rankings.